Clinical Xenotransplantation: A Suggested Next Step
Xenotransplantation · 2026-05 · 33 (3)
DOI: 10.1111/xen.70133 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Xenotransplantation, online erschienen am 21.06.2026. Verfasst von David K C Cooper und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center For Transplantation Sciences, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Transplantation, Heterologous, Kidney Transplantation, Islets of Langerhans Transplantation, Diabetic Nephropathies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: American Society of Nephrology, U.S. Department of Health and Human Services, NIH HHS.
Abstract (Originalsprache)
Recent progress has been made toward introducing gene‐edited (GE) pig heart and kidney xenotransplantation into clinical practice. In particular, the outcomes of GE pig kidney transplantation have been promising, with three recipients currently surviving between 3 and 9 months after transplantation. These encouraging results highlight the growing feasibility of xenotransplantation as a solution to the shortage of human donor organs. In the United States and many other countries, nearly half of all patients on kidney transplant waiting lists are diabetic. Individuals with diabetic nephropathy often achieve better outcomes when they receive both kidney and islet allotransplants, as this combination restores renal function and improves glucose control. Therefore, such patients would be ideal candidates for combined GE pig kidney and islet xenotransplantation. Because immunosuppressive therapy is essential to maintain a kidney graft, performing a simultaneous islet transplant is clinically justifiable. Studies in nonhuman primates have demonstrated that porcine islet transplantation can achieve long‐term glucose regulation, supporting its translational potential. For the foreseeable future, until complications such as post‐transplant proteinuria are fully resolved, we propose that patients with diabetic nephropathy receive a human kidney allotransplant in combination with a GE pig islet xenotransplant to optimize outcomes and improve long‐term metabolic stability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center For Transplantation Sciences, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.
- Imagine Pharma, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: David K C Cooper, Rita Bottino
Förderung
- American Society of Nephrology
- U.S. Department of Health and Human Services
- NIH HHS
- National Institutes of Health
Zitieren
APA
Cooper, D. K. C., & Bottino, R. (2026). Clinical Xenotransplantation: A Suggested Next Step. Xenotransplantation, 33(3). https://doi.org/10.1111/xen.70133
Vancouver
Cooper DKC, Bottino R. Clinical Xenotransplantation: A Suggested Next Step. Xenotransplantation. 2026;33(3). doi:10.1111/xen.70133
BibTeX
@article{Cooper2026,
author = {Cooper, David K C and Bottino, Rita},
title = {Clinical Xenotransplantation: A Suggested Next Step},
journal = {Xenotransplantation},
year = {2026},
volume = {33},
number = {3},
doi = {10.1111/xen.70133}
}
EUVIMED